Form 4: Vera Therapeutics CEO Marshall Fordyce Reports Stock Sales to Cover Tax Obligations
SEC Form 4 Filing
Marshall Fordyce, CEO of Vera Therapeutics, reports sales of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units and sales pursuant to a pre-arranged trading plan.
Summary
- Marshall Fordyce, the President and CEO of Vera Therapeutics, reported the sale of Class A Common Stock.
- The sales were executed on February 21, 2025, February 25, 2025, and February 26, 2025.
- A total of 19,688 shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- The sales were conducted at weighted-average prices ranging from $27.5526 to $28.3183.
- An additional 1,100 shares were sold pursuant to a Rule 10b5-1 trading plan adopted on April 23, 2024.
- Following these transactions, Fordyce directly owns 204,665 shares of Class A Common Stock and indirectly owns 222,030 shares through a GRAT.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing primarily reports routine stock sales for tax obligations and pre-planned transactions. It doesn't inherently indicate positive or negative sentiment about the company's future.
Industry Context
Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the sales are related to tax obligations and a pre-arranged trading plan, which are generally viewed as less impactful than discretionary sales.
Key Dates
| Date | Description |
|---|---|
| 2022/08/26 | Date of election intended to satisfy the conditions of Rule 10b5-1(c) made by the Reporting Person. |
| 2024/04/23 | Date the Reporting Person adopted a Rule 10b5-1 trading plan. |
| 2025/02/21 | First transaction date for shares sold to cover tax withholding obligations. |
| 2025/02/25 | Second transaction date for shares sold to cover tax withholding obligations. |
| 2025/02/26 | Transaction date for shares sold pursuant to Rule 10b5-1 trading plan. |
| 2025/02/27 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.